Santos Guilherme Palhares Aversa, Sesso Ricardo, Lugon Jocemir Ronaldo, de Menezes Neves Precil Diego Miranda, Barbosa Abner Mácola Pacheco, da Rocha Naila Camila, Modelli de Andrade Luis Gustavo
Department of Internal Medicine, UNESP, Univ Estadual Paulista, Av. Prof. Montenegro, Distrito de, Botucatu, SP, 18618-687, Brazil.
, Rubião Jr, S/N18.618-687, Botucatu, SP, Brazil.
J Nephrol. 2024 Dec;37(9):2601-2608. doi: 10.1007/s40620-024-02120-5. Epub 2024 Oct 25.
Patients who travel more than 60 min to undergo hemodialysis may experience higher mortality and lower quality of life. The primary aim of this study was to calculate the travel distance between patient city areas and dialysis facility care locations in Brazil, to highlight barriers and need to optimize access to chronic dialysis.
We conducted a retrospective cohort study using claims data from the Brazilian Public Health System's database, focusing on kidney replacement therapy (KRT) by hemodialysis. Our study population comprised all patients undergoing hemodialysis in Brazil between January 2023 and December 2023. For patients from different city areas, we calculated the Haversine distance between the patient city area and the dialysis facility.
We evaluated 154,788 patients who received hemodialysis funded by the Brazilian Public Health System. Fifty-nine percent of the patients underwent dialysis in the same city area. Overall, patients traveled a median (IQR) distance of 35.9 [19.5 - 64.2] kilometers to the facilities, 48% traveled more than 40 km, with a maximum traveling distance of 353 km. Notably, the median distance traveled was shortest in the Southeast (27.6 km) and longest in the North (84.3 km). The number of patients that traveled more than 40 km was lower in the Southeast (32%) and higher in the North region (77%).
The travel distance to the dialysis facility is an important inequity to KRT access in Brazil. In the South and Southeast, where there is a higher dialysis unit density, patients have greater regional availability of dialysis centers, and shorter traveling distances than in the North, Midwest, and Northeast regions.
前往接受血液透析路程超过60分钟的患者可能面临更高的死亡率和更低的生活质量。本研究的主要目的是计算巴西患者所在城市区域与透析设施护理地点之间的旅行距离,以突出障碍并强调优化慢性透析可及性的必要性。
我们使用巴西公共卫生系统数据库中的理赔数据进行了一项回顾性队列研究,重点关注血液透析的肾脏替代治疗(KRT)。我们的研究人群包括2023年1月至2023年12月期间在巴西接受血液透析的所有患者。对于来自不同城市区域的患者,我们计算了患者所在城市区域与透析设施之间的哈弗辛距离。
我们评估了由巴西公共卫生系统资助接受血液透析的154,788名患者。59%的患者在同一城市区域接受透析。总体而言,患者前往设施的中位(IQR)距离为35.9 [19.5 - 64.2]公里,48%的患者行程超过40公里,最大行程距离为353公里。值得注意的是,东南部的中位行程距离最短(27.6公里),北部最长(84.3公里)。行程超过40公里的患者数量在东南部较低(32%),在北部地区较高(77%)。
前往透析设施的旅行距离是巴西肾脏替代治疗可及性方面的一个重要不平等因素。在南部和东南部,透析单位密度较高,患者可获得的透析中心区域可用性更高,且行程距离比北部、中西部和东北部地区短。